Frequency Therapeutics’ hearing loss treatment showed early signs of efficacy last year, with some patients showing improvements after a few months. Now, as the biotech plugs away at a phase 2a study, ...
Concertgoers, rejoice: An early safety study of Frequency Therapeutics’ hearing loss drug treatment has cleared its first hurdles while showing some signs of hearing improvement in certain patients.
Astellas Pharma will partner with Frequency Therapeutics to develop Frequency’s lead candidate—the Phase IIa-bound sensorineural hearing loss regenerative therapeutic FX-322—through a collaboration ...
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, a biotechnology company spearheading the movement to harness the regenerative potential of target populations of progenitor stem cells inside ...
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, a clinical stage biotechnology company, today announced the addition of two new members to its PCA Regenerative Medicine Scientific Advisory ...
SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...
2020 APR 20 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators publish new report on Aging Research - Geriatrics and Gerontology. According to news reporting from ...
Considering how “frequency generator for healing” has hit breakout status on Google Trends and Amazon now hosts a growing ...